Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (141)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Lazertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Lazertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Furmonertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Furmonertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Almonertinib (Furmonertinib)	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Almonertinib (Furmonertinib) Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Rezivertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Rezivertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Sunvozertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Sunvozertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Zorifertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Zorifertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Crizotinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Crizotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Ceritinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Ceritinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Alectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Alectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Brigatinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Brigatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Lorlatinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Lorlatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Entrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Entrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor

Lazertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Furmonertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Almonertinib (Furmonertinib) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Rezivertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Sunvozertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Zorifertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Crizotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Ceritinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Alectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Brigatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Lorlatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Entrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor

‹ 1 2 3 4 … 12 ›

Product Range

Company

Global Network

Products

Lazertinib

Furmonertinib

Almonertinib (Furmonertinib)

Rezivertinib

Sunvozertinib

Zorifertinib

Crizotinib

Ceritinib

Alectinib

Brigatinib

Lorlatinib

Entrectinib

Lazertinib

Furmonertinib

Almonertinib (Furmonertinib)

Rezivertinib

Sunvozertinib

Zorifertinib

Crizotinib

Ceritinib

Alectinib

Brigatinib

Lorlatinib

Entrectinib